ET
ESTRIGENIX THERAPEUTICS, INC.
SEC filingPharmaceuticals · Wauwatosa, WI
Amount raised$1Msold at filing
Total offering$2M$1M still open
Investors in the raise1count reported to the SEC
FiledJul 27, 2026first sale Jul 17, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Patricia SchellerDirector
Victoria ZellmerExecutive Officer
William DonaldsonExecutive Officer, Director
Daniel SemExecutive Officer, Director
Karyn FrickExecutive Officer
Executive officers, directors and promoters as listed on the Form D.